Mary DiBiase
Chief Operating Officer en X4 PHARMACEUTICALS, INC. .
Fortuna: 405 535 $ al 31/03/2024
Perfil
Mary DiBiase is currently the Chief Operating Officer at X4 Pharmaceuticals, Inc. She started this position in 2021.
Prior to her current role, she held several positions in the pharmaceutical industry.
From 1995 to 2011, she worked at Biogen, Inc. as a Senior Director-CMC Management.
In 2011, she joined Pfizer Inc. as the Vice President-Product Operations.
From 2013 to 2016, she worked at EPIRUS Biopharmaceuticals, Inc. as the VP-Technical Operations & Program Management.
Dr. DiBiase holds a doctorate degree from the University of Rhode Island and an undergraduate degree from the University of London.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC.
0.17% | 11/03/2024 | 291 752 ( 0.17% ) | 405 535 $ | 31/03/2024 |
Cargos activos de Mary DiBiase
| Empresas | Cargo | Inicio |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Chief Operating Officer | 08/09/2021 |
Antiguos cargos conocidos de Mary DiBiase.
| Empresas | Cargo | Fin |
|---|---|---|
| EPIRUS BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
| PFIZER, INC. | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2011 |
Formación de Mary DiBiase.
| University of Rhode Island | Doctorate Degree |
| University of London | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Mary DiBiase
